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Introduction
Systemic lupus erythematosus (SLE) is a systemic autoim-
mune disease characterized by the production of a number
of autoantibodies [1]. To date, the etiology of this disorder
remains unknown, although genetic, environmental, and hor-
monal factors appear to influence disease manifestations.
There is little information about the molecular mechanisms
underlying autoantibody production by SLE patients. It has
been suggested that autoantibodies may arise from
somatic hypermutation of immunoglobulin genes that have
minimal capacity to bind autoantigens in their germline
configuration [2–9]. Support for an important role of
Abstract
To assess the impact of somatic hypermutation and selective influences on the Vλ light chain
repertoire in systemic lupus erythematosus (SLE), the frequency and pattern of mutations were
analyzed in individual CD19+ B cells from a patient with previously undiagnosed SLE. The mutational
frequency of nonproductive and productive rearrangements in the SLE patient was greater (3.1 × 10–2
vs 3.4 × 10–2, respectively) than that in normal B cells (1.2 × 10–2 vs 2.0 × 10–2, both P < 0.001). The
frequencies of mutated rearrangements in both the nonproductive and productive repertoires were
significantly higher in the patient with SLE than in normal subjects. Notably, there were no differences
in the ratio of replacement to silent (R/S) mutations in the productive and nonproductive repertoires of
the SLE patient, whereas the R/S ratio in the framework regions of productive rearrangements of
normal subjects was reduced, consistent with active elimination of replacement mutations in this
region. The pattern of mutations was abnormal in the SLE patient, with a significant increase in the
frequency of G mutations in both the productive and nonproductive repertoires. As in normal subjects,
however, mutations were found frequently in specific nucleotide motifs, the RGYW/WRCY
sequences, accounting for 34% (nonproductive) and 46% (productive) of all mutations. These data
are most consistent with the conclusion that in this SLE patient, the mutational activity was markedly
greater than in normal subjects and exhibited some abnormal features. In addition, there was
decreased subsequent positive or negative selection of mutations. The enhanced and abnormal
mutational activity along with disturbances in selection may play a role in the emergence of
autoreactivity in this patient with SLE.
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somatic hypermutation comes from the observation that
immunization of mice with pneumococcal polysaccharide
can lead to the emergence of anti-dsDNA autoantibodies
by somatic hypermutation [3,10]. In addition, V gene
rearrangements encoding high-affinity anti-dsDNA anti-
bodies in mouse and man are highly mutated [10] and
back mutation of mutated human V genes to the germline
sequence results in a loss of anti-DNA binding [9].
Despite the likelihood that autoantibodies may arise from
somatic hypermutation, there is only limited information on
the nature and extent of immunoglobulin-gene mutations in
patients with SLE. Moreover, the human Vλ gene reper-
toire has not been examined in detail, largely because it
has been delineated only recently [11,12]. The potential
importance of the Vλ repertoire in autoimmunity is sug-
gested by the apparent overrepresentation of Vλ gene
products in autoantibodies [8,13–18].
The production of autoantibodies in SLE is thought to rep-
resent an example of immune dysregulation with a resul-
tant break in tolerance. However, the nature of the
abnormality in immunoregulation remains a matter of
debate. We have previously found a number of abnormali-
ties in patients with SLE that could contribute to the emer-
gence of autoimmunity [19,20], including an increase in
the mutational activity directed toward VH and Vκ genes
[21,22] and an enhancement of receptor editing/revision
[19,20]. In this study, we examined the impact of somatic
hypermutation on Vλ rearrangements, which could be par-
ticularly important because of the frequent use of Vλ
genes by autoantibodies [8,13–18].
The data derived by single-cell polymerase chain reaction
(PCR) analysis of genomic DNA from individual B cells
clearly document two abnormalities, namely, enhanced muta-
tional activity with a bias of G mutations, and diminished
selection. Together, these abnormalities could have con-
tributed to the emergence of autoimmunity in this patient.
Materials and methods
See Supplementary material.
Results
Frequency of mutations in peripheral B cells of a
patient with SLE
Of the 57 nonproductive VλJλ rearrangements analyzed,
45 (79%) contained one or more nucleotide changes.
Only 12 nonproductive sequences (21%) were unmu-
tated. Of the 108 productive VλJλ gene rearrangements,
95 (88%) were mutated and 13 (12%) did not harbor
mutations. In normal subjects studied previously [23],
27/55 nonproductive Vλ rearrangements (49%) contained
mutations. In the productive repertoire of the normal sub-
jects, 100/174 sequences (58%) harbored mutations.
Overall, the VλJλ repertoires of the patient with SLE exhib-
ited a significantly greater frequency of mutated
sequences in both the nonproductive and the productive
repertoire (P < 0.001 for both).
The mutational frequencies of the nonproductive and pro-
ductive repertoires are shown in Table 1. There was a sig-
nificantly higher mutational frequency in the productive
than in the nonproductive rearrangements when the entire
set of VλJλ genes was considered (P = 0.022) but not
when only the mutated Vλ rearrangements were analyzed.
In normal subjects, by comparison, the mutational fre-
quency of the productive rearrangements with mutations
(2.0 × 10–2 per base pair) was significantly greater than
that of the mutated nonproductive repertoire (1.2 × 10–2
per base pair, P < 0.001).
Further analyses assessed mutations in the complemen-
tarity-determining regions (CDRs) and framework regions
(FRs). Of all mutations of Vλ in the patient with SLE, 42%
(174/412) of the nonproductive and 44% (356/807) of
the productive rearrangements were in CDRs, while the
respective values for FRs were 58% (238/412) and 56%
(451/807). The corresponding values in normal controls
were 65% of the nonproductive and 58% of the produc-
tive mutations in CDRs, versus 35% and 42%, respec-
tively, in FRs [23]. In normal subjects, the frequency of
mutations was significantly higher in the CDRs than in the
FRs (P < 0.005), in both nonproductive and productive
rearrangements, contrasting with the SLE patient’s signifi-
cantly higher frequency of FR mutations in both reper-
toires (P < 0.005).
Comparison of ratios of replacement mutations to
silent mutations (R/S)
The frequency of replacement (R) mutations in the CDRs
and FRs in the nonproductive and productive repertoires
was comparable in the SLE patient (Table 2), whereas the
normal subjects had a reduced R/S ratio in the FRs of the
productive repertoire (P < 0.05). Overall, the R/S ratios
found in the nonproductive and productive repertoires of the
patient with SLE did not greatly differ. However, this patient
had a significantly higher R/S ratio in the CDRs than in FRs
compared with normal subjects, in both the nonproductive
(P < 0.01) and the productive (P < 0.001) repertoire.
In comparison with the normal subjects, the patient with
SLE had a significantly higher R/S ratio in CDRs
(P < 0.005) but not in FRs.
Distribution of mutations in Vλ λJλ λ gene rearrangement
See Supplementary material.
Nature of base-pair substitutions
As shown in Fig. 1, there were some striking differences in
the nature of the nucleotide substitutions between the
patient with SLE and normal subjects. Based on the
occurrence of the base pairs in the germline sequencesArthritis Research    Vol 3 No 6 Dörner et al
and the assumption of a random mutational process, the
expected distribution of mutations would be as follows: T,
23%; C, 31%; A, 21%; and G, 25%. However, in the
patient, 41% of Gs were mutated (169/412; Fig. 1), sig-
nificantly exceeding the expected frequency of 25%
(P < 0.001). In contrast, 23% of As were mutated
(95/412) – a value close to the 21% that would be
expected by chance. The frequencies of mutations of T
(14%, 59/412) and C (22%, 89/412) were significantly
lower than would be expected (both P < 0.001).
Similarly, in the productive repertoire, 40% of Gs
(319/807,  P < 0.001) were mutated significantly more
than expected, whereas T (89/807, 11%, P < 0.001) and
C (152/807, 19%, P < 0.001) were mutated significantly
less than expected. Again A (31%, 247/807) was mutated
at a frequency not significantly different from the fre-
quency of the occurrence of A in the germline of the pro-
ductive repertoire (25%).
Comparison of specific mutations between the nonpro-
ductive and productive repertoires (Fig. 1) shows that in
the patient with SLE, mutations of A were significantly
more frequent in the productive (31%) than in the nonpro-
ductive repertoire (23%, P < 0.005). In this patient, similar
frequencies of mutations were found for G, C, and T in the
nonproductive versus the productive repertoire. (For addi-
tional data, see Supplementary material).
Table 1
Mutational frequency of the nonproductive and productive Vλ λ repertoires of the patient with systemic lupus erythematosus (SLE)
and normal subjects
Patient with SLE Normal subjects
Nonproductive Productive χ2 P < Nonproductive Productive χ2 P <
Number of Vλ nucleotides 16679 28496 12679 39225 0.001
Number of Vλ nucleotides in  13194 23819 6339 21821 0.001
mutated rearrangements
Number of mutations 412 807 76 440
Mutational frequency of all  2.5 2.8 0.022 0.60 1.12 0.001
VλJλ gene rearrangements (%)
Mutational frequency of mutated  3.1 3.4 NS 1.19 2.02 0.001
VλJλ gene rearrangements (%)
J = joining [region]; NS = not significant; V = variable [region].
Table 2
Ratio (R/S) of replacement mutations to silent mutations in regions of Vλ λ in a patient with SLE and in normal human subjects
Patient with SLE Normal subjects*
Region of Vλ Nonproductive rearrangements Productive rearrangements Nonproductive rearrangements Productive rearrangements
FR1 1.0b (4/4) 7.3b (29/4) 0.0 (0) 1.8 (9/5)
CDR1 7.8 (47/6) 6.3a (113/18) 3.0 (12/4) 3.9a (55/14)
FR2 3.1 (49/16) 2.5 (95/38) 0.0b (11/0) 1.8b (51/29)
CDR2 8.2 (41/5) 10.9 (76/7) 10.0 (10/1) 4.8 (48/10)
FR3 2.9 (112/39) 3.1 (185/59) 4.0 (12/3) 2.4 (66/28)
CDR3 8.7 (52/6) 8.0a (96/12) 3.0 (15/5) 3.7a (81/22)
FRs 2.8 (165/59) 3.1a (309/101) 7.7b (23/3) 2.0a,b(126/62)
CDRs 8.2 (140/17) 7.7a (285/37) 3.7 (37/10) 4.0a (184/46)
Total 4.0 (305/76) 4.3a (594/138) 4.6 (60/13) 2.9a (310/108)
*The data for normal subjects have been published elsewhere [23]. aSignificant difference between ratio in SLE patient and normal subjects; 
P < 0.05 (χ2 test). bSignificant difference between ratio in nonproductive and productive rearrangements; P < 0.05 (χ2 test). 
CDR = complementarity-determining region; FR = framework region.In the nonproductive and productive repertoires of the
SLE patient, purine transversions (37% and 38%, respec-
tively) and purine transitions (30% and 32%, respectively)
were the most frequent substitutions (Table 3). Pyrimidine
transversions (17% and 15%, respectively) and pyrimidine
transitions (16% and 14%, respectively) were found sig-
nificantly less frequently in both repertoires (P < 0.001 for
both). In the normal subjects, purine transversions (30%)
and purine transitions (25%) were more frequent than
pyrimidine transversions (21%) and pyrimidine transitions
(24%), although these differences were not significant.
Detailed analysis of the findings for the SLE patient
revealed that G-to-A substitutions occurred frequently in
the nonproductive (21.6%) and productive (18.6%) reper-
toires. By contrast, mutations from T to A (2.7%) were
infrequent. Mutations from A to G were significantly differ-
ent between the nonproductive (8.0%) and productive
(13.0%) repertoires (P = 0.01). Mutations of G to A were
significantly increased in the CDRs versus FRs in both the
nonproductive and productive repertoires (5.8% vs
15.8%,  P < 0.005, in the nonproductive repertoire and
6.9% vs 11.7%, P < 0.005, in the productive repertoire).
Mutations within RGYW and WRCY motifs – analysis of
mutational targeting in the patient with SLE
Since previous studies identified the RGYW motif on both
DNA strands as a target of the mutational machinery
[24–27], we made further analyses to determine the tar-
geting of these motifs in the nonproductive and productive
gene repertoires of this patient with SLE.
In the nonproductive Vλ repertoire, 94/412 mutations
(23%) were part of RGYWs and 49/412 mutations (12%)
were found in the inverse repeat of RGYW, WRCY. Alto-
gether, 143/412 (35%) mutations were located within
these motifs in the nonproductive repertoire. In the pro-
ductive repertoire, 200/807 mutations (25%) were
included within RGYW and 168/807 mutations (21%)
were included within WRCY sequences. Thus, 368/807
mutations (46%) were found within these targeted motifs
Available online http://arthritis-research.com/content/3/6/368
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Figure 1
Frequency of mutated base pairs of the nonproductive and productive
Vλ gene repertoires of the patient with systemic lupus erythematosus
in comparison with those found in normal subjects. NHS = normal
human subjects; SLE = systemic lupus erythematosus.
Table 3
Nature of base-pair substitutions 
Substitution to
Nonproductive Vλ rearrangements Productive Vλ rearrangements
Region of
substitution Substitution from T C A G T C A G
CDR T - 2.9 1.0 0.5 - 1.9 1.4 1.1
C 2.9 - 0.2 3.4 3.0 - 1.1 1.3
A 5.8 2.4 - 4.1 7.0 3.1 - 6.7
G 7.8 5.3 5.8b - 6.1 4.7 6.9b -
FR T - 2.6 1.7 3.1 - 2.9 1.7 2.0
C 7.5 - 3.4 4.1 6.8 - 2.0 4.5
A 4.2 2.7 - 3.9 5.0 2.6 - 6.3
G 5.3 3.4 15.8b - 5.3 4.8 11.7b -
Total T - 5.5 2.7 3.6 - 4.8 3.1 3.1
C 10.4 - 3.6 7.5 9.8 - 3.1 5.8
A 10.0 5.1 - 8.0a 12.0 5.7 - 13.0a
G 13.1 8.7 21.6 - 11.4 9.5 18.6 -
aComparison of nonproductive and productive Vλ genes; P < 0.05 (χ2 test). bComparison between mutations in the CDRs and FRs; P < 0.005 (χ2
test). CDR = complementarity-determining region; FR = framework region.in the productive repertoire. The contribution of mutations
within RGYW/WRCY sequences was significantly differ-
ent between the nonproductive and productive repertoires
(P < 0.001). Similarly, there was a significant difference
between the mutations within RGYW/WRCY sequences
in the nonproductive (38%) and the productive repertoires
(51%) of normal subjects (P = 0.033) [23], but there were
no significant differences between normal subjects and
the SLE patient.
Discussion
In this study, we analyzed the frequency and distribution of
mutations of Vλ chain rearrangements obtained from indi-
vidual peripheral B cells of a patient with early, previously
undiagnosed SLE and compared the findings with previ-
ous findings for normal subjects. A previous study of the V
gene usage of the patient showed that central receptor
editing of the Vλ and peripheral editing of Vκ gene
rearrangements were more active than in normal subjects
[19,20]. Recent analysis of mutations of VH and Vκ
rearrangements from this patient also revealed significant
differences in comparison with normal subjects [21,22],
including a greater mutational frequency, enhanced muta-
tions of Gs, comparable targeting of RGYW/WRCY
motifs, and apparent abnormalities of selective influences
shaping the mutated V gene repertoire.
Differences between the patient and normal subjects in
the frequencies and patterns of mutations in the nonpro-
ductive repertoire are likely to reflect abnormalities in
mutational activity. The current study indicates that the
mutational machinery was significantly more active in this
untreated SLE patient than in normal subjects, as judged
from the number of mutated Vλ genes and from the
mutational frequencies; these findings are consistent
with findings of Vκ and VH rearrangements from this
patient [21,22]. These results suggest that the entire
immunoglobulin-gene repertoire was mutated to a
greater degree than in normal subjects. By contrast, de
Wildt et al [28] recently reported no differences in the
mutational activity in SLE patients from that in normal
subjects. However, that study analyzed individual
rearrangements of IgG+ B cells from two patients with
‘SLE–mixed connective tissue disease’. Differences
between the patients analyzed, the impact of treatment,
the effects of preincubating individual B cells with EL-4
B5 thymoma cell lines, and the selection of B cells pro-
ducing immunoglobulin in that study could explain appar-
ent differences from our present study. In addition, the
mutational frequencies estimated in the study of de Wildt
et al [28] (ranging from 4.8% to 8.8%) cannot be com-
pared with our present data, because of methodological
differences (analysis of mRNA from a defined subpopula-
tion and stimulation before the analysis). Moreover,
detailed mutational analyses were not reported, preclud-
ing a firm conclusion.
Another indication of abnormal activity was the over-
whelming contribution of G mutations. In the patient with
SLE, 41% of all mutations in the nonproductive repertoire
and 40% in the productive repertoire were nucleotide
changes of G. The same overabundance of G mutations
was found in VH rearrangements (39% in the nonproduc-
tive and 42% in the productive repertoire) and Vκ
rearrangements (50% in the nonproductive and 53% in
the productive repertoire) of this patient [21,22]. This is
noteworthy because previous analyses of VH (26% in the
nonproductive and 26% in the productive repertoire) [24]
and Vκ gene rearrangements (30% in the nonproductive
and 28% in the productive repertoire) [29] in normal sub-
jects provided no evidence for preferential mutation of G.
Alternatively, it cannot be formally excluded that the prefer-
ential mutation of G mutations is an idiosyncrasy of this
SLE patient. Additional studies will be necessary to
assess this possibility.
Although the mutational machinery was markedly
enhanced in peripheral B cells of this patient in compari-
son with that in normal subjects, it remains likely that the
CD19+ B cells analyzed contained a higher percentage of
memory B cells. Therefore, comparison with the previously
reported IgM+ B cells may have overestimated the appar-
ent mutational frequency in the SLE patient. Significantly
more mutated Vλ rearrangements were found in the SLE
patient than in CD19+ B cells of a normal individual [23] –
a finding consistent with the conclusion that the frequency
of memory B cells is higher in SLE. Indeed, a recent study
[30] identified a higher proportion of CD27+ memory B
cells carrying somatically mutated V rearrangements in the
periphery of SLE patients. However, even when analyses
were confined to VλJλ rearrangements with mutations, the
mutational frequencies of the nonproductive and produc-
tive repertoires were significantly greater in the SLE
patient, indicating that, in addition, the impact of muta-
tional activity on memory cells of this patient was greater
than in normal subjects.
Additional evidence of major abnormalities in selection
became apparent when the mutational frequencies of pro-
ductive and nonproductive Vλ repertoires were compared.
Whereas there were clear indications of positive selection
of mutations in Vλ rearrangements in normal subjects, with
increased mutational frequencies in productive compared
with nonproductive repertoires (1.2% vs 2.0%, respec-
tively, P < 0.001) [23], no such difference was noted in
the Vλ repertoires of the SLE patient. A similar pattern
was previously noted in the Vκ [21] and VH gene reper-
toires [22,24].
As opposed to normal subjects, no clear evidence of posi-
tive selection of mutations was found in the SLE patient.
This positive selection of mutations was documented by
almost comparable mutational frequencies, the distribution
Arthritis Research    Vol 3 No 6 Dörner et alof mutations within codons, and the R/S ratios of produc-
tive and nonproductive rearrangements, which are all con-
sistent with the conclusion that the imprint of selection as
evidenced by differences between the nonproductive and
productive repertoires was not as evident as previously
identified in normal subjects.
Although there was evidence of differences in mutational
activity in the SLE patient, overall targeting of mutations to
RGYW motifs on both DNA strands, as manifested in
normal subjects [23,24,26,31–34] by an increased muta-
tional frequency of RGYW/WRCY motifs on the sense
strand [23,27,33], appeared to be intact in the SLE
patient. However, the lack of positive selection of RGYW
mutations (mutational frequency 16% in both the nonpro-
ductive and the productive repertoire) was remarkably dif-
ferent from what is seen in normal subjects, who
manifested clear evidence of positive selection of RGYW
mutations. The increase of WRCY mutations from the non-
productive (10%) to the productive (17%) repertoire was
very similar to normal subjects and patients with another
autoimmune disease, Sjögren’s syndrome [31,35] These
findings suggest that there are unique abnormalities in the
selection of mutations in patients with SLE.
Our study identified markedly enhanced mutational activity
and distinct abnormalities in mutational targeting, in a
patient with active, untreated SLE compared with normal
subjects. In addition, there was decreased subsequent
positive or negative selection. These abnormalities may be
involved in the emergence of autoreactivity in this patient
with SLE.
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Supplementary material
Supplementary materials and methods
The patient analyzed fulfilled the revised criteria for classi-
fication of SLE [S1] and the case has been described in
detail previously [19,20].
Preparation of peripheral blood mononuclear cells, fluores-
cence-activated cell sorting of individual CD19+ B cells,
and the method of PCR amplification of human Vλ gene
rearrangements have been described in detail recently
[S2].
The single-cell PCR methodology used made it possible
to amplify genomic DNA of immunoglobulin-gene
rearrangements from peripheral B cells and, thereby, avoid
biases inherent in analyzing cell lines or cDNA libraries
[S3,S4]. Since genomic DNA was amplified, productive
as well as nonproductive Vλ rearrangements could be
amplified, sequenced, and analyzed. Analysis of the non-
productive repertoire is especially important in assessing
the immediate impact of somatic hypermutation, as the
nonproductive rearrangements do not encode a protein
and therefore do not influence selection of B cells
expressing these rearrangements. In contrast, the distribu-
tion of B cells can be shaped by a variety of selective influ-
ences during development and subsequent antigenic
stimulation, based upon the nature of the expressed
immunoglobulin heavy or light chain.
Determination of Taq polymerase fidelity and the
frequency of potential sequence errors
The PCR error rate for this analysis has been documented
to be approximately 1 × 10–4 errors/base pair [24]. Thus,
few if any of the nucleotide changes encountered in this
analysis can be ascribed to amplification errors.
Statistical analysis
The previously published [23] mutational frequency and
pattern of hypermutation of VλJλ rearrangements from two
healthy normal male donors (26 and 45 years old) served
as a basis of comparison. Both the nonproductive and
productive repertoires of these two normal, age-disparate
donors exhibited an overall similar usage of Vλ and Jλ
gene elements [S2].
Sequences were analyzed with the χ2 test to compare the
differences in the mutational frequencies between the
VλJλ rearrangements of the SLE patient and the normal
subjects. The goodness-of-fit χ2 test was used to
compare the nature of individual mutations of nucleotides
to their expected mutational frequencies based on their
occurrence in the germline. P values < 0.05 were consid-
ered to be statistically significant.
Mutational ‘hot spots’ were identified by determining the
mean number of mutations of each codon and identifying
codons that had more mutations than the mean +1.96 SD
(95% confidence interval) of the mean mutations of the
group [24]. In this analysis, the overall mutations of both
nonproductive and productive gene repertoires were
assessed excluding the portions of FR1 that could not be
analyzed because of the primers used.
Supplementary results
Distribution of mutations in Vλ λJλ λ gene rearrangement
Previous analyses in normal subjects detected specific
codon positions with a higher mutability within the Vλ
rearrangements [23]. Thus, in normal subjects, codon
position 51 was found to be mutated significantly more
frequently in the nonproductive repertoire, whereas codon
positions 38, 50, 51, 53, 95a, and 95b of productive gene
rearrangements were more frequently mutated.
The patient with SLE, however, manifested some notable
differences (Supplementary Fig. 1). Significantly more
mutations (outside of the 95% confidence interval) were
detected in codon positions 53 and 94 of nonproductive
rearrangements and in positions 33, 38, 50, 51, 53, 66,
and 94 in the productive repertoire. No mutations
occurred in codon positions 23, 35, 40, 44, 63, or 88 of
the nonproductive or 63 of the productive repertoire.
Thus, whereas mutational hot spots at positions 38, 50,
51, and 53 in the productive repertoire were similar
between normal subjects and the patient with SLE, there
were additional hot spots in FRs of the patient.
Nature of base-pair substitutions
Comparing the mutational frequency of base pairs
between the nonproductive repertoire of the patient and
that of the controls, mutations of T were found more fre-
quently in normal subjects (30%) than in the patient with
SLE (14%, P < 0.001), whereas mutations of G were
Arthritis Research    Vol 3 No 6 Dörner et almore frequent in the patient’s repertoire (41%) than in the
controls (25%, P < 0.005). Base substitutions of A and C
occurred at comparable frequencies in the patient and in
normal subjects.
In the productive repertoires, substitutions of G were also
found significantly more frequently in the patient (40%)
than in normal subjects (29%, P < 0.001). By contrast, C
(27%) and T (17%) nucleotides were mutated significantly
more frequently in normal subjects than in the patient (C,
19%; T, 11%; P < 0.005 each).
RGYW/WRCY mutations
When the number of RGYW/WRCY mutations was com-
pared with the occurrence of these motifs in the germline
sequences, 16% of RGYW sequences (94/601) and
10% of WRCY motifs (49/487) contained mutations in
the nonproductive repertoire. The difference in these
mutational frequencies was significant (16 versus 10%,
P < 0.007). In the productive repertoire, 16% (200/1250)
and 17% (168/993), respectively, of these sequences
were also found to be mutated and the frequency of muta-
tions did not differ significantly between them (P = 0.56).
Only the difference of WRCY mutations was significant
when the nonproductive and productive repertoires were
compared (10% vs 16%, P < 0.001). Overall, there was a
significant difference between the mutational frequency of
RGYW/WRCY quartets in the nonproductive repertoire
(13%, 143/1088) and the productive repertoire (16%,
368/2243, P = 0.014, Supplementary Fig. 2).
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Supplementary Figure 1
Distribution of mutational events within the nonproductive (left panel) and productive (right panel) Vλ rearrangements in CD19+ B cells from a
patient with systemic lupus erythematosus. The percentages of mutated codon positions are given and the mutational hot spots are indicated.
Mutational hot spots were determined as described in Supplementary materials and methods. Codons used only by a few rearrangements were not
considered in the diagram. CDR = complementarity-determining region.
Supplementary Figure 2
Mutational frequencies of RGYW sequences and those of their inverse
repeats, WRCY, in the nonproductive and productive Vλ gene
repertoires of the patient with SLE and in normal control subjects. SLE
= systemic lupus erythematosus.